| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
| mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |